[EN] 3-SUBSTITUTED PYRIDAZINE COMPOUNDS AS SMARCA2 AND/OR SMARCA4 DEGRADERS<br/>[FR] COMPOSÉS PYRIDAZINE 3-SUBSTITUÉS UTILISÉS EN TANT QU'AGENTS DE DÉGRADATION DE SMARCA2 ET/OU DE SMARCA4
申请人:[en]AURIGENE ONCOLOGY LIMITED
公开号:WO2023152666A1
公开(公告)日:2023-08-17
The present invention provides 3-substituted pyridazine compound of formula (I), which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or prevention of diseases or disorders dependent upon SMARCA2 and/or SMARCA4 in a subject. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.